Differentiation therapy for IDH1/2 mutant malignancies

Cell Research

Volumn 23, Issue 8, 2013, Pages 975-977

  Garrett Bakelman, Francine E ^a   Melnick, Ari M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881186135     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.73     Document Type: Article

References (10)

1. Dang L, Jin S, Su SM. Trends Mol Med 2010; 16:387-397.
2. Figueroa ME, Abdel-Wahab O, Lu C, et al. Cancer Cell 2010; 18:553-567.
3. Lu C, Ward PS, Kapoor GS, et al. Nature 2012; 483:474-478.
4. Losman JA, Looper RE, Koivunen P, et al. Science 2013; 339:1621-1625.
5. Shih AH, Abdel-Wahab O, Patel JP, et al. Nat Rev Cancer 2012; 12:599-612.
6. Sasaki M, Knobbe CB, Itsumi M, et al. Genes Dev 2012; 26:2038-2049.
7. Wang F, Travins J, Delabarre B, et al. Science 2013; 340:622-626.
8. Rohle D, Popovici-Muller J, Palaskas N, et al. Science 2013; 340:626-630.
9. Sasaki M, Knobbe CB, Munger JC, et al. Nature 2012; 488:656-659.
10. Wang ZY, Chen Z. Blood 2008; 111:2505- 2515.